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ABSTRACT Glucose metabolism of the bo-
vine embryo is low during the first cleavages and
increases sharply after the major resumption of the
genome (8–16 cells). The mRNA level for genes in-
volved in glucose metabolism was tested by RT-PCR on
individual oocytes and embryos at different stages of
development. These genes were: glucose transport
GLUT-1, hexokinase (HK), glucose-6-phosphate-dehydro-
genase (G6PDH), and glucose-phosphate-isomerase
(GPI); actin was used as a reference transcript. RT-PCR
results revealed three types of oocytes or embryos:
positive with a PCR signal for each transcript consid-
ered, nul with no signal for any transcript, and heteroge-
neous with a PCR signal for some transcripts and none
for others. The number of nul and heterogeneous
samples was higher for slow than for fast-cleaving
embryos (81% vs. 36%), and the proportion of positive
embryos increased significantly at the 16-cell and
morula stages (P , 0.002), suggesting a correlation
between mRNA content and developmental capacity. In
positive embryos, GLUT-1 mRNA level was reduced by
half during maturation and fertilization. Actin and hexoki-
nase mRNA levels decreased during the first cleavages,
but significantly increased at the 16-cell and morula
stages, respectively. GPI transcript remained stable
throughout development, whereas there was a signifi-
cant rise for G6PDH at the 4-cell stage, perhaps due to
a polyadenylation process. Finally, the absence or
decrease in intensity of several transcripts at the blastocyst
stage suggests suboptimal culture conditions. Mol. Re-
prod. Dev. 48:216–226, 1997. r 1997 Wiley-Liss, Inc.
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INTRODUCTION:
During early preimplantation stages, mammalian em-
bryos do not metabolize much, if any, glucose. Moreover, in
most species, in vitro early development is hampered in the
presence of glucose, whereas later it may be required to
support normal morula-blastocyst transition (reviewed by
Leese, 1995; Barnett andBavister, 1996).
Glucose uptake by in vitro produced bovine embryos
increases steadily from the two-cell stage up to hatch-
ing blastocyst, whereas the increase in metabolism
occurs mainly in two steps: one corresponding to the
major onset of embryonic transcription (8–16 cell stage),
the other at the time of compaction (Rieger et al., 1992).
Although there is always some activity of the pentose
phosphate pathway, the main metabolic pathway for
glucose after the 8–16 cell stage and up to the blastocyst
stage is glycolysis (Thompson et al., 1996).
Enzymatic studies in mouse and human embryos
revealed that the switch to glucose utilization involves
mainly the enzyme 6-phosphofructokinase (PFK) (Bar-
behenn et al., 1974) with a possible role for hexokinase
and glucose transport (Gardner and Leese, 1988). Enzy-
matic reactions may be regulated at various levels. The
amount of enzyme depends on the level of transcription,
the stability of the message, and its rate of translation,
but the activity of the protein also may depend on
posttranscriptional regulation.
The purpose of this work was to study the regulation
of transcription for several enzymes involved in glucose
metabolism in individual in vitro produced bovine embryos
according to their developmental stage and kinetics of
cleavage, which is considered to be a criterion of develop-
mental capacity (Bolton et al., 1989; Van Soom et al., 1992;
Grisart et al., 1994;McKiernan andBavister, 1994).
The bovine embryo relies on maternal transcripts
and proteins up to the eight-cell stage when the major
onset of zygotic transcription occurs (Frei et al., 1989).
Metabolic changes during this period could depend on
variable patterns of transcription for some of the en-
zymes we measured: hexokinase (HK) and the glucose
transporter GLUT-1, which, as reported above, have
been involved in the glucose switch, glucose-6-phos-
phate dehydrogenase (G6PDH) as a potential indicator
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of the pentose phosphate pathway (PPP) activity, and
glucose-phosphate-isomerase (GPI) being involved in
glycolysis. b-actin was chosen as a reference transcript.
MATERIALS AND METHODS
Embryo Production
Oocytes were collected by puncturing ovarian fol-
licles from slaughtered cows. Intact cumulus-oocyte
complexes (COCs) were matured for 20 hr in TCM 199
supplemented with 10% fetal calf serum (FCS), then
fertilized with percoll separated spermatozoa at a con-
centration of 2.106 per ml in TALP medium. At 24 hr
postinsemination (HPI), zygotes were stripped of cumu-
lus cells by vortexing and cultured for 7 days in 30 µl
droplets of modified SOF medium with 3 mg/ml of BSA
under 5% CO2 and 5% O2 (Van Langendonckt et al.,
1997), which contained 25–30 embryos.
In a first experiment, two-cell embryos were selected
at 30 HPI, pooled, and cultured in drops already used
for the first 10 hr of culture. One control drop was left
intact. Each drop was assigned to one particular devel-
opmental stage. Embryos were selected at 45 HPI for
the four-cell stage, 70 HPI for the 5–8 cell stage, 118
HPI for the 9–16 cell stage, 140 HPI for the morula
stage, and 165 HPI for the blastocyst stage. This timing
was first established in conditioned medium (Grisart et
al., 1994), but was quite similar in mSOF 1 BSA (Van
Langendonckt et al., 1997).
In a second experiment, some immature, mature, and
fertilized oocytes (20 HPI) were harvested. The remain-
ing zygotes were cultured and collected 30 HPI for the
two-cell, 45 HPI for the four-cell, and 70 HPI for the
eight-cell stages. In this case, uncleaved oocytes and
two-cell embryos at 45 HPI, as well as four-cell embryos
at 70 HPI, were also collected as samples of slow-
cleaving or blocking embryos.
Once selected according to this scheme, oocytes and
embryos were treated with 0.25% trypsin for 5 min at
37°C, vortexed for 5 min to remove all cumulus cells,
washed five times in PBSwithoutMg11 and Ca11, then
stored individually in a minimal volume of deionised
water (1–3 µl) at 270°C. Complete removal of cumulus
cells by this method was confirmed by examining under
a fluorescent microscope 20 immature oocytes treated
the same way, stained with Hoechst 33342, and exam-
ined for contaminating nuclei.
RNAExtraction and Reverse Transcription
After the addition of 20 µg of glycogen as a carrier, the
total RNA of each individual oocyte or embryo was
extracted with 100 µl of ultraspec (Biotecx) and 20 µl of
chloroform, vortexed 15 sec, then centrifuged to sepa-
rate organic and aqueous phases. RNAwas precipitated
by adding two volumes of ethanol to the aqueous phase.
The RNA pellet obtained after centrifugation was
washed with 75% ethanol, then briefly dried before
being dissolved in 5 µl of deionised DEPC-treated
water. In the second experiment, a fixed amount of a
reporter RNA was added to each sample in order to
check the reproducibility of the method. This reporter
RNA was produced from a mutated piece of the bovine
hexokinase cDNA under a SP6 RNA polymerase pro-
moter and followed by a polyA tail.
To unravel RNA secondary structure, samples were
heated at 90°C for 5 min, then quick-chilled on ice, and
immediatelyreverse-transcribed.Reverse transcriptionwas
performed at 37°C for 1 hr in a 10 µl volume containing 50
mM Tris-HCl, pH 8.3; 75 mM KCl; 3 mM MgCl2; 200 ng
oligodT(12–18) (Pharmacia); 1 mM of each dNTP (Pharma-
cia), 15 U. RNAGuard (Pharmacia), and 100 U. MMLV
reverse transcriptase (Gibco-BRL).After reverse transcrip-
tion, the volume of each samplewas increased to 30 µl.
PCRAmplification
Primers. Primer pairs were obtained from Eurogen-
tech (Allandale, NJ) or from Gibco-BRL (Gaithersburg,
MD). These 20-base-long primers were selected accord-
ing to the bovine sequence for hexokinase (Griffin et al.,
1989), glucose transport GLUT-1 (Boado and Par-
dridge, 1991), and for b-actin (Degen et al., 1983). When
the bovine sequence was not available, primers were
chosen from interspecies conserved regions of the cDNA
according to the mouse sequence for glucose-6-phos-
phate-dehydrogenase (G6PDH) (Zollo et al., 1993) and
the human sequence for glucose-phosphate-isomerase
(GPI) (Walker et al., 1990). All these primer pairs
spanned at least an intron in order to differentiate RNA
from DNAamplification (Table 1). The location and size
of the introns were predicted according to rat or human
genomic data. The selected introns were rather small,
so DNAand RNAamplified bands were in the same size
range, except for GLUT-1. Amplicons of the expected
size were subsequently digested by one or two restric-
tion enzymes in order to confirm their identity.
Amplification. Each amplification was done sepa-
rately on 1/6th of the reverse transcription reaction in a
50 µl final volume containing 1.5 mM MgCl2; 50 mM
KCl; 10 mM Tris-HCl, pH 8.3 with 0.5 µM of primers;
0.05 mM of each dNTPs (Pharmacia, Gaithersburg,
MD), and 1 unit of Taq polymerase (Dynazym). After a
hot start of 6 min at 95°C, 35 cycles of amplification
were performed as follows: denaturation at 95°C for 40
sec, annealing at 55–59°C (according to the primer
pairs used) for 50 sec, extension at 72°C for 1 min. A
final extension step of 5 min at 72°C ended the reaction.
Detection and quantitation. One-tenth of the am-
plification product was separated on 4% agarose gel and
stained with ethidium bromide or 6% acrylamide gel
coloured with silver nitrate. The image of each gel was
digitized and the signal intensity for each PCR product
quantitated by densitometric scanningwith a computer-
assisted image analysis system (NIH image v 1.56). The
conditions of staining and imaging were normalized
from one gel to another according to the intensity of the
267 bp band of molecular weight pBR322/Hae III.
Semiquantitative RT-PCRAssay
For each pair of primers some preliminary amplifica-
tion experiments were carried out on a fixed amount of
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RNAderived from bovine oviduct cells. These cells were
scraped from a fresh oviduct and cultured for 24 hr
under TCM 199 with 10% calf serum before being
harvested. RNA was extracted with ultraspec as for
oocytes and embryos, then quantified by spectrophotom-
etry. As the bovine oocyte contains ,1 ng of total RNA
(Olszanska and Borgul, 1993), 1 ng of RNAfrom oviduct
cells was reverse transcribed and amplified as de-
scribed previously. At this RNA concentration, the
amplification reaction was stopped at every cycle from
cycles 26–40, and the range of cycle numbers over
which the amplification reaction was clearly exponen-
tial was established. This cycle number subsequently
served to check that amounts of added RNA, ranging
from 5 ng to 0.1 ng, gave a proportional output of
amplicons.
The efficiency of RNA extraction and reverse tran-
scription was checked by the PCR product that was
obtained for the reference RNAadded to each sample in
the second experiment.
Statistical Analysis
The significance of differences in proportions was
investigated by using logit linear models (Grizzle et al.,
1969; Freeman, 1987). Levels of different mRNAs were
analyzed by log-normal linear ANOVA models (McCul-
lagh and Nelder, 1983). Different features of the ob-
served proportions and mRNA level trends were as-
sessed by using local polynomial contrasts; the a
posteriori character of these contrasts is accounted for
by the Scheffe method (Arnold, 1971). The statistical
significance of theminima andmaximawas assessed by
testing the nullity of local quadratic contrasts. Null
hypotheses were rejected at the conventional P 5 0.05
level of significance.
RESULTS
Validity of the RT-PCRAssay
Primer pairs were chosen to give a different signal for
RNA or DNA amplification, and the identification of all
RT-PCR products was confirmed by restriction diges-
tion. Examples of PCR results are presented in Figure
1. Several nonreverse transcribed embryos and other
negative controls at different levels of the manipulation
were included (data not shown).
Preliminary studies on amplification reactions showed
that, for a fixed amount of initial RNA (1 ng), our
system detected a linear increase in PCR products after
30 or 35 cycles of amplification according to the primer
pairs (Fig. 2A). With 35 cycles, the intensity of ampli-
TABLE 1. Primers Used for PCR
Gene Primer sequence Reference
Size RNA restriction
DNA bp RNA bp Enzyme Fragments size
B-ACTIN
Sens 58 GCGTGACATCAAGGAGAAGC 38 bovine (Degen) 643 432 Dde I 216, 140, 54
Antisens 58 TGGAAGGTGGACAGGGAGGC 38 rat (Nudel)
HK
Sens 58 TGCGGCTCTCTGATGAAACT 38 bovine (Griffin) 355 166 Dde I 137, 29
Antisens 58 TCCAGGGCGATGAAATCTCC 38 rat (Kogure) Sma I 94, 72
G6PDH
Sens 58 CAAGATGATGACCAAGAAGC 38 mouse (Zollo) 407 200 Ava I 163, 37
Antisens 58AGCAGTGGTGTGAAGATACG 38 human (Chen)
GLUT-1
Sens 58 CGCTATTTGTGGTGGAACGA 38 bovine (Boado) ? 345 Dde I 216, 129
Antisens 58 CGGTGAAGATGATGAAGACG 38 rat (Williams) Eag I 322, 23
GPI
Sens 58 CGCCCAACCAACTCTATTGT 38 human (Walker) 188 101 Bgl II 77, 24
Antisens 58 CAGATGATGCCCTGAACGAA 38
Fig. 1. PCR and RT-PCR products obtained on DNA (D) or RNA (R)
extracted from bovine oviduct cells and amplified using five different
pairs of primers. The validation of the PCR product on RNA is done by
restriction diagnosis (Ava I, Bgl II, or Dde I 1 R). All sizes are in base
pairs and bands ,60 bp are not visualized on these gels. pBR322/Hae
III fragments are used as molecular weight (MW).
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cons was linearly correlated with variable amounts of
initial RNA, ranging from 0.1 ng up to 5 ng, which is in
the range of bovine oocyte total RNA (Fig. 2B). Conse-
quently, the intensity of each PCR product obtained on
a single oocyte or embryo depends on the initial quan-
tity of mRNA in the sample.
The PCR products obtained on the exogenous polyA-
RNA, which was added in the second experiment, were
quite similar from sample to sample and confirmed the
reproducibility of the method (see Fig. 6). The signal
was completely lost for one embryo out of the 160
treated. That sample was excluded from our results.
General Transcriptional Data
The yield of blastocysts in the control drop was 30%
vs. 62% for two-cell embryos selected at 30 HPI. In the
first experiment, 10 mature oocytes and 129 fast-
cleaving embryos could be individually analyzed by
RT-PCR. In the second experiment, 160 samples were
treated, 32 of themwere delayed oocytes or embryos.As
the results obtained from the two experiments were not
significantly different, they were gathered in Table 2.
The data on one- and two-cell embryos at 45 HPI, as
well as four-cell embryos at 70 HPI, were pooled in one
category called ‘‘slow-cleaving embryos.’’ The total of
the 2-, 4-, 8-, 16-cell, morula, and blastocyst embryos
collected under the time scheme described above were
named ‘‘fast-cleaving embryos.’’
Out of the 298 samples treated, 175 (59%) displayed a
signal for each PCR performed and were called positive;
39 (13%) did not give PCR products with any primer
pairs except for the exogenous added RNA. For these
oocytes or embryos, the RNA was degraded before the
manipulation, so they were called nul. Finally, 84 (28%)
oocytes or embryos showed a strong signal for some
primer pairs and none for other pairs. They were called
heterogeneous.
Positive samples represented 64% of the oocytes and
fast-cleaving embryos against only 19% for the slow-
cleaving ones. The relationship between the percentage
of positive samples and their developmental stage was
tested with logit-linearmodeling. Significant (P , 0.05)
differences between developmental stages were found
(Fig. 3). The quadratic behavior between the two-cell
and morula stages shows a highly significant minimum
(P 5 0.002) at the eight-cell stage. The two maxima of
the curve at the two-cell and morula stages are not
significant (P 5 0.09 and P 5 0.06, respectively), al-
though it is approaching significance for the morula
peak. The same analysis with heterogeneous samples
gave the opposite result as the distribution of nul
oocytes or embryos did not show statistically significant
variation according to developmental stage.
Different heterogeneous types could be observedwhen
one or more mRNAs were undetectable. Two cases were
frequent (88%): either a nul actin and a strong signal
for G6PDH, called G type (I in Fig. 4.), or the opposite
with no signal for G6PDH and a strong actin signal,
called A type (II in Fig. 4). The other signals were
variable, hexokinase, and GPI, being mostly positive,
and GLUT-1, mostly negative (GPI and GLUT-1 signals
are not shown in Fig. 4). TheA type is present mainly in
the early stages, and none is described in slow-cleaving
embryos, whereas the ‘‘G type’’ is the only one described
for this category and the most frequent one for all
stages (Table 2).
Expression Pattern for Different GenesAnalyzed
In order to design temporal patterns of expression,
only positive samples of the two experiments were
considered. In the first experiment, the patterns went
from themature oocyte up to the blastocyst stage; in the
Fig. 2. Validation of the semiquantitative RT-PCRprocedure regard-
ing the number of cycles (A) or regarding the amounts of RNA input
(B). mRNA was isolated from oviduct cells, reverse transcribed then
amplified separately with the five different pairs of primers. After gel
separation, RT-PCR products were quantitated by densitometric
scanning of the digitized image. Densities were expressed in A
relatively to the signal obtained with 25 cycles, RNA input was fixed at
1 ng. In B, it was expressed relatively to the signal obtained with 0.15
ng, PCR cycles number was fixed to 35.
TABLE 2. Developmental Distribution of Oocytes and













Oocytes 85 54 (64) 12 (14) 19 (22) 11 (58) 6 (32)
2-cell 25 20 (80) 2 (8) 3 (12) 2 (67) 1 (33)
4-cell 38 23 (60) 3 (8) 12 (32) 7 (58) 2 (17)
8-cell 47 22 (47) 6 (13) 19 (40) 14 (74) 2 (11)
16-cell 24 16 (67) 2 (8) 6 (25) 4 (67) 0 (0)
Morula 18 16 (89) 0 (0) 2 (11) 2 (100) 0 (0)
Blasto 29 18 (62) 5 (17) 6 (21) 5 (83) 1 (17)
Slow
cleaving 32 6 (19) 9 (28) 17 (53) 17 (100) 0 (0)
Total
samples 298 175 (59) 39 (13) 84 (28) 62 (74) 12 (14)
Total fast
cleavingb 181 115 (64) 18 (10) 48 (27) 34 (71) 6 (13)
*Overall significant differences in developmental distribution
(P , 0.05).
aPercentage expressed in function of the number of heteroge-
neous samples only.
bSum of the 2-, 4-, 8-, 16-cell, morula, and blastocyst.
GENE EXPRESSION IN BOVINE OOCYTES/EMBRYOS 219
second experiment, they went from the immature oo-
cyte to the 8-cell stage, the data being excluded from
delayed embryos. In that second experiment, GLUT-1
results were available, but there was no more informa-
tion on endogenous hexokinase as it competed for
amplification with our reporter RNA. The results ob-
tained for actin, G6PDH, and GPI in the two experi-
ments were not statistically different, so they were
pooled in order to design temporal patterns of expres-
sion (Fig. 5). For these three genes, the data are
expressed as the mean of 15–24 individual values for
each developmental stage.
Actin. There was a small decrease from the imma-
ture oocyte up to the eight-cell stage, the actin mRNA
level being finally reduced by half (P 5 0.01). Actin
mRNA then showed a sharp, highly significant rise
starting at the 16-cell stage and lasting up to the
morula stage (P 5 0.001). The drop at the blastocyst
stage was also significant (P 5 0.01).
Glucose-6-phosphate-dehydrogenase. The strik-
ing feature here was a maximum in PCR products at
the four-cell stage. This increase can be visualised in
Figure 6. The quadratic component of this peak was
highly significant (P 5 0.003).
Glucose-phosphate-isomerase. This transcript
was very stable during maturation, fertilization, and
preimplantation development. Individual values within
or between stages were quite similar.
Results on hexokinase and GLUT-1 were derived
from one experiment only, experiment 1 for hexokinase
and experiment 2 for GLUT-1. As a consequence, there
were no data available for hexokinase about immature
and fertilized oocytes, whereas for GLUT-1, there were
no data available for development after the ZGA.
Between 7–18 individual values were pooled for each
developmental stage (Fig. 5).
Hexokinase. There was a highly significant drop in
the mRNA level starting at the four-cell stage and
reaching a minimal value at the 8- and 16-cell stages
(P 5 0.001), followed by a sharp rise at the morula
stage (P 5 0.001). As for actin, a significant drop in the
amount of PCR products was observed as the embryo
proceeded to the blastocyst stage (P 5 0.05).
GLUT-1. There was a strong decrease occurring
during maturation and fertilization. The level reached
at the two-cell stage was significantly different from the
value observed in the immature oocyte (P 5 0.01).
From the two-cell stage up to the eight-cell stage, the
amount in PCR products did not change.
DISCUSSION
About 30–35% of the bovine oocytes originated from
abattoir ovaries, matured and fertilized in vitro, reach
the blastocyst stage in culture (Brackett and Zuelke,
1993). Not only are the oocytes collected in that way an
extremely heterogeneous form of material (Gordon and
Lu, 1990), but also in vitro maturation conditions are
not equivalent to the in vivo process (Greve, 1987;
Hyttel, 1989). Consequently, some oocytes of our experi-
ments have not acquired their developmental compe-
tence. Although only morphologically normal oocytes
were selected, 36% of them, whether immature, ma-
ture, or fertilized, had an abnormal mRNA content (nul
or heterogeneous). Crozet et al. (1986) and Fair et al.
Fig. 3. Probability of occurence (solid line) for different ‘‘RNA
categories’’ of oocytes or embryos as a function of the developmental
stage (probabilities estimated by the observed proportions, Table 2).
The confidence interval (P 5 0.95) is given by the dotted line. Statisti-
cal analysis of these categorical data was done by linear models.
Results mostly showed a significant minimum of positive embryos at
the eight-cell stage (P 5 0.002), as well as a correlated maximum of
heterogeneous embryos at the same stage. The proportion of nul
embryos showed no significant variation throughout development.
Note that the approximation used to compute the linear categorical
model does not provide an accurate confidence interval when the
observed proportion is zero, which is the case at the morula stage. O:
immature, mature, and fertilize oocytes; 2-c: 2-cell; 4-c: 4-cell; 8-c:
8-cell; 16-c: 16-cell; M: morula; B: blastocyst. Pos.: positive sample with a
PCR product for each transcript analyzed, Nul: samples with no PCR
product for any transcript analyzed;Heterog.: heterogeneous sampleswith
a PCRproduct for some transcripts, whereas none for others.
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(1995) showed that small size oocytes or those derived
from small size follicles (which is correlated) had a high
RNA synthesis, whereas larger oocytes exhibited little
or no RNAactivity. The first ones probably have not yet
stored the needed amount of RNA to ensure further
development. This could corroborate our observation.
After the selection of the two-cell embryos at 30 HPI,
described as the best ones (Grisart et al., 1994), the
percentage of embryos with an abnormal RNA content
decreased from 36% to 20%. Although not significant,
this can suggest a correlation between embryo quality
and mRNAcontent. As embryonic development reaches
the four- and eight-cell stages, the percentages rise to
40% and 53%, respectively.An exaggerated degradation
of maternal mRNA could be a possible explanation. In
cattle embryos, total protein synthesis gradually de-
clines from the zygote stage to reach a minimum at the
eight-cell stage (Frei et al., 1989). In the mouse, this
protein decline is correlated with a sudden loss of
maternal mRNA (Bachvarova et al., 1985). For the
bovine embryo, the major zygotic gene activation (ZGA)
starts at the eight-cell stage (King et al., 1988; Kopecny
et al., 1989; Barnes and Eyestone, 1990). Both the
increase in embryonicmRNAand the selective degrada-
tion of maternal mRNA are necessary for a correct
maternal-zygotic transition (MZT) (reviewed by Telford
et al., 1990), and this critical step is often associated
with early developmental arrest (Eyestone and First,
1991). About 60% of the selected two-cell embryos will
become blastocysts, but 40% of them will block earlier,
mainly at the 5–8 cell stages. The 40% and 53%,
respectively, of four- and eight-cell embryos with an
abnormal mRNA content could constitute that popula-
tion of blocking embryos. When zygotic transcription is
prevented by a-amanitin, some embryos will reach the
9–16-cell stage, but not any further (Barnes and First,
1991). It could explain the remaining 33% of nul and
heterogeneous embryos at the 16-cell stage, whereas
very few of them (11%) are found at the morula stage.
Only embryos with sufficient maternal mRNA and a
correct MZT could reach this critical developmental
step. Reaching the blastocyst stage seems to be a new
challenge, at least in our in vitro conditions, where the
medium is unchanged for all the culture period. At the
blastocyst stage, the number of positive embryos de-
creases and patterns of expression for some genes,
mainly actin and hexokinase, fall. Such RNA degrada-
tion for a cellular component as ubiquitous as actin is
unexpected when both the cell number and the net
weight of the embryo should be increasing. It is also
surprising to see a decrease in hexokinase mRNAwhen
glucose consumption should be higher to ensure the
cavitation process. mRNA degradation could be due to
nonoptimal in vitro conditions. Similarly, Wrenzycki et
al. (1996) have reported that the connexin 43 transcript
is missing in in vitro produced bovine blastocysts,
whereas this transcript is present at previous embry-
onic stages and in blastocysts produced in vivo.
We should note that due to a high percentage of
embryos with an abnormal mRNA content during the
Fig. 4. PCR Products obtained with three different pairs of primers
after individual RNA extraction and RT-PCR on two-cell embryos.
PCR product for actin (a), for Glucose-6-phosphate dehydrogenase (g6)
and for hexokinase (hk). A shows three positive embryos with a PCR
signal for the three primers pairs; B shows heterogeneous embryos
with either a good signal for G6PDH while the actin band is absent (G
type, or I), or a nice signal for actin while the G6PDH band is weak (A
type, or II). Hexokinase signal is always present here.
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Fig. 5.
4-, 8- and 16-cell stages, patterns of expression de-
signed from pools of embryos will often reveal an
exaggerated mRNAdecay during these stages.
The degradation rate of RNA messengers can vary
according to the mRNA species (Paynton et al., 1988).
Both the mRNAstructure and its intracellular environ-
ment will influence the turnover (reviewed by Ross,
1996). Furthermore, Ho et al. (1994) showed that for
mouse embryos, NaCl concentration in the culture
medium has a different influence on the stability of
various mRNAs before the morula stage. Surprisingly,
in the present study some embryos displayed a strong
signal for hexokinase, GPI, or G6PDHmRNAs, whereas
the actin mRNA signal, chosen as a reference for
embryo quality, was very weak, or even absent. Since
actin mRNA is ubiquitous, its stability must be more
quickly affected by suboptimal conditions than other
genes. G6PDH and GPI transcripts are the most stable
in delayed or blocked embryos. GLUT-1 is the first
signal to disappear, but as its initial molecule count is
unknown, its early disappearance could be due to
unstability or scarcity.
Bovine b-actin mRNA is reduced by half during the
early stages, then shows a sharp rise simultaneously
with the ZGA. A similar pattern is reported for the
mouse with a drop during oocyte maturation up to the
end of the two-cell stage, followed by a sharp rise, also
coincident with ZGA (Bachvarova et al., 1989; Taylor
and Piko, 1990). According to the technique used, the
range of this drop varies (Paynton et al., 1988; Temeles
et al., 1994; Rhambatla et al., 1995). The increase in
b-actin mRNA after the ZGA could reflect a higher cell
number, but also a higher number of transcripts per cell
(Heikinheimo et al., 1995). The low level of actin at the
blastocyst stage is unexplained. We have already pro-
posed the hypothesis that our in vitro conditions are not
optimal for blastocyst survival.
The transcription of enzymes implicated in glucose
metabolism may be discussed in terms of their chrono-
logical appearance in glucose consumption. Glucose is
known to enter into preimplantation mouse embryos
through facilitative diffusion mediated by the GLUT
proteins (Gardner and Leese, 1988). RT-PCR on mouse
embryos have demonstrated the presence of theGLUT-1
isoform throughout preimplantation development and
the GLUT-2 isoform after the eight-cell stage (Hogan et
al., 1991). Some of our unpublished results demon-
strate that GLUT-1 transcript is also present through-
out preimplantation development in cattle, but we have
semiquantitative data only up to the eight-cell stage.
GLUT-1 mRNA level is decreased by half during matu-
ration and fertilization. This can be explained by the
general degradation of maternal mRNA initiated dur-
ing oocyte maturation, which affects 50% of some
mRNAs (Paynton, 1988). The low level of remainining
mRNA could account for the weak glucose uptake
during the early stages as described by Rieger (1992). It
will be interesting to obtain semiquantitative data after
the major resumption of the embryonic genome. In the
mouse, GLUT-1 expression increases sharply between
the two-cell and the blastocyst stage (Morita et al.,
1994), but here again this increase is far lower for in
vitro produced blastocysts. As the bovine sequence of
GLUT-2 isoform is unknown and not well conserved
between species, we were unable to check its presence.
Intracellular glucose is phosphorylated by hexoki-
nase. The temporal pattern of hexokinase shows a
sharp decrease from the four-cell stage up to the 16-cell
stage, followed by a strong increase at the morula stage
coincident with the second increase in glucose consump-
Fig. 6. PCR products obtained for actin and G6PDH transcripts,
after individual RNAextraction and reverse transcription as described
in Materials and Methods, on 10 immature oocytes and 10 embryos at
the four-cell stage picked at 45 HPI. For each sample, results of the
amplification on the exogenous added polyARNA are also reported.
The mean value of the PCR product obtained on G6PDH transcript is
clearly more elevated for the four-cell embryo than for the immature
oocyte.
Fig. 5. Temporal pattern of expression for several genes during
bovine oocyte maturation, fertilization, and preimplantation embry-
onic development (IO: immature oocyte, MO: mature oocyte, FZ:
fertilized zygote, 2-c, 4-c, 8-c, 16-c: 2-cell, 4-cell, 8-cell, 16-cell, M:
morula and B: blastocyst). Oocytes or embryos were individually
RT-PCR as described in Materials and Methods. After gel separation,
signals corresponding to PCR products were quantified by densitomet-
ric scanning of the digitized image. Calibration was done according to
a standard included in each gel and efficiency of RNA extraction and
RT was controlled by the amplification of the reference RNA. Results
are integrated OD. Final data are expressed as the mean and
confidence interval for the mean (P 5 0.95). For Actin, G6PDH, and
GPI, there were two experiments pooled, or an average of 18 indi-
vidual values for each developmental stage. Black and white circles
are used to plot the means corresponding to the two separate
experiments. Preliminary tests have showed no experiment-treatment
interaction so that a restricted model excluding the corresponding
terms was used to estimate a common curve (squares). For hexokinase
and GLUT-1, there were only one experiment and an average of 13
individual values at each stage. Consequently for hexokinase, there
were no data on immature and fertilized oocyte, whereas GLUT-1
pattern of expression is not going further the eight-cell stage.
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tion (Rieger et al., 1992). A similar dramatic increase
for the enzyme activity at the morula stage has been
reported for the mouse (Hooper and Leese, 1988; Ayabe
et al., 1994) and human embryos (Martin et al., 1993)
but in these studies, the activity was low from the
oocyte to themorula stage, whereas we showed here the
presence of maternal transcripts for hexokinase, which
gradually disappears before being replaced by zygotic
mRNA. A recent study (Houghton, 1996) also reported
the presence of HK transcript throughoutmouse preim-
plantation development. Either these maternal tran-
scripts are not translated into proteins, or their corre-
sponding activity is too low to be detected. This enzyme
also can be inhibited by cellular compartmentalization
(Miccoli et al., 1996).
Glucose-6-phosphate can be transformed into glyco-
gen, metabolized through the pentose-phosphate path-
way (PPP), or through glycolysis. We have no informa-
tion about glycogen formation, but we have investigated
the PPP activity according to the expression of G6PDH,
which catalyzes the first and irreversible step of this
pathway. Our temporal expression pattern for G6PDH
does not correspond to the protein activity pattern
described for othermammalian species. Inmice, G6PDH
activity drops suddenly upon ovulation (De Schepper et
al., 1985), then stabilizes up to the eight-cell stage and
again falls abruptly afterward (Leese, 1987), whereas a
more gradual decline was observed for human embryos
(Martin et al., 1993). This down regulation seems to be
due to a decrease in the number of molecules rather
than to a change in kinetic properties (De Schepper et
al., 1993), and according to the same study, embryonic
transcription of this X-linked enzyme is unlikely as the
distribution of its activity was not bimodal, whereas
females should express twice as many molecules as
males. Our results do not show any decrease in G6PDH
transcript while development proceeds, but underline a
significant temporary increase at the four-cell stage
before the major ZGA. As our reverse transcription is
done with oligo dT, changes in the amount of PCR
products can correspond to a change in transcript
abundance, but also to a change in the polyadenylation
state. Polyadenylation can modify the stability and the
rate of translation of the mRNA. This kind of regulation
has been described for the cdk4 gene in the mouse
embryo (Moore et al., 1996). The G6PDH gene is
described as a ‘‘sentinel’’ for oxidative stress, leading
rapidly to the generation of NADPH for maintenance of
the cellular redox state. This adaptive response is
mainly due to an increase in transcription, mRNA
stability, and the rate of protein synthesis (reviewed by
Kletzien et al., 1994). So the increase in PCR product
detected here could be due to changes inmRNApolyade-
nylation due to suboptimal in vitro conditions. Experi-
ence with a-amanitin, which prevents zygotic transcrip-
tion, could test this hypothesis. In addition, it has been
reported that for in vivo produced bovine embryos, the
activity of the PPP increases threefold after 24 hr of
culture and is significatively higher for poor quality
embryos (Javed andWright, 1990).
For the glycolytic pathway, phosphofructokinase
(PFK) is the key enzyme, but its activity is mostly
regulated at a posttranslational level with an allosteric
control by ATP and several other metabolites. Glucose-
phosphate-isomerase (GPI) catalyzes the interconver-
sion of the glucose-6-phosphate and fructose-6-phos-
phate, a reaction near to equilibrium. In the mouse, the
transition from oocyte-coded to embryo-coded GPI has
been extensively studied by exploiting its numerous
genetic variants. The oocyte-coded GPI activity is stable
until the eight-cell stage and then declines, whereas
embryonic GPI can be detected at the early morula
stage (West et al., 1986). For both mouse and human
embryos, a high level of GPI activity is maintained
during the early preimplantation period, but then falls
to a minimum at the blastocyst stage in mice. There is
no evidence of such a decline in humans (West et al.,
1989). In the present study, the temporal pattern of GPI
transcripts is quite stable according to developmental
stage. This could be due, as inmice, to a high stability of
the maternal transcripts, but also to a gradual and
balanced substitution by embryonic transcripts.
In conclusion, RT-PCR studies have indicated that
some bovine oocytes and embryos have an abnormal
mRNAcontent. Their distribution, according to develop-
mental stages or kinetics of cleavage, suggests a corre-
lation between mRNA content and developmental ca-
pacities. Increase of hexokinase mRNAs at the morula
stage could be responsible for the increase in glucose
consumption described at compaction, whereas the low
level of GLUT-1 mRNA after oocyte maturation is
perhaps the reason for a low glucose uptake during the
first cleavages. Increase in G6PDHPCR products at the
four-cell stage could be an adaptative process to culture
conditions. The absence or drop in intensity for several
transcripts in blastocysts probably suggests that our in
vitro culture conditions are nonoptimal.
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